[HTML][HTML] A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria

MK Laufer, PC Thesing, FK Dzinjalamala, OM Nyirenda… - 2012 - journals.plos.org
Background The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

MK Laufer, PC Thesing, FK Dzinjalamala, OM Nyirenda… - PLoS ONE, 2012 - go.gale.com
In the long struggle to control and ultimately eliminate malaria, the development of
resistance to antimalarial drugs has caused repeated setbacks. Chloroquine and …

[PDF][PDF] A Longitudinal Trial Comparing Chloroquine as Monotherapy or in

MK Laufer, PC Thesing, FK Dzinjalamala, OM Nyirenda… - 2012 - pdfs.semanticscholar.org
Background: The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria.

MK Laufer, PC Thesing, FK Dzinjalamala… - PLoS …, 2012 - search.ebscohost.com
Background: The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

[HTML][HTML] A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

MK Laufer, PC Thesing, FK Dzinjalamala… - PLoS ONE, 2012 - ncbi.nlm.nih.gov
Background The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.

MK Laufer, PC Thesing, FK Dzinjalamala, OM Nyirenda… - Plos one, 2012 - europepmc.org
Background The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria

MK Laufer, PC Thesing, FK Dzinjalamala, OM Nyirenda… - 2012 - pubmed.ncbi.nlm.nih.gov
Background The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

[PDF][PDF] A Longitudinal Trial Comparing Chloroquine as Monotherapy or in

MK Laufer, PC Thesing, FK Dzinjalamala, OM Nyirenda… - 2012 - Citeseer
Background: The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

[引用][C] A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

MK Laufer, PC Thesing, FK Dzinjalamala… - PLoS …, 2012 - ui.adsabs.harvard.edu
A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate,
Azithromycin or Atovaquone-Proguanil to Treat Malaria - NASA/ADS Now on home page ads …

A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.

MK Laufer, PC Thesing, FK Dzinjalamala, OM Nyirenda… - 2012 - cabidigitallibrary.org
Background: The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …